Redcare Pharmacy NV
XETRA RDC.DE
Redcare Pharmacy NV Price to Earnings Ratio (P/E) on January 14, 2025: -197.51
Redcare Pharmacy NV Price to Earnings Ratio (P/E) is -197.51 on January 14, 2025, a 4.63% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
-
Redcare Pharmacy NV 52-week high Price to Earnings Ratio (P/E) is -160.26 on May 21, 2024, which is 18.86% above the current Price to Earnings Ratio (P/E).
-
Redcare Pharmacy NV 52-week low Price to Earnings Ratio (P/E) is -273.56 on November 11, 2024, which is -38.51% below the current Price to Earnings Ratio (P/E).
-
Redcare Pharmacy NV average Price to Earnings Ratio (P/E) for the last 52 weeks is -217.53.
Key data
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
Market news
Loading...
XETRA: RDC.DE
| CEO | Mr. Olaf Heinrich |
| IPO Date | Aug. 9, 2017 |
| Location | Netherlands |
| Headquarters | Erik de Rodeweg 11–13 |
| Employees | 1,725 |
| Sector | Health Care |
| Industries | |
Description
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email